Literature DB >> 17178273

Drug interaction of tizanidine and ciprofloxacin: case report.

Kenji Momo, Masato Homma, Yukinao Kohda, Norio Ohkoshi, Toshihiro Yoshizawa, Akira Tamaoka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17178273     DOI： 10.1016/j.clpt.2006.08.017

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  6 in total

1.  Tizanidine-induced hypotension in patients with liver cirrhosis.

Authors:  Kenji Momo; Masato Homma; Makoto Abei; Ichinosuke Hyodo; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

2.  Coadministration of tizanidine and ciprofloxacin: a retrospective analysis of the WHO pharmacovigilance database.

Authors:  Annette Rudolph; Hendrike Dahmke; Hugo Kupferschmidt; Andrea Burden; Stefan Weiler
Journal:  Eur J Clin Pharmacol       Date:  2021-01-06       Impact factor: 2.953

3.  Evaluation of community pharmacists' knowledge about drug-drug interaction in Central Saudi Arabia.

Authors:  Ziyad Alrabiah; Abdulaziz Alhossan; Sultan M Alghadeer; Syed Wajid; Salmeen D Babelghaith; Mohamed N Al-Arifi
Journal:  Saudi Pharm J       Date:  2019-01-07       Impact factor: 4.330

4.  Tizanidine-induced acute severe cystitis in a female taking famotidine.

Authors:  Resham Raj Poudel; Nisha Kusum Kafle
Journal:  Clin Pharmacol       Date:  2015-07-29

5.  Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports.

Authors:  Caterina Palleria; Christian Leporini; Serafina Chimirri; Giuseppina Marrazzo; Sabrina Sacchetta; Lucrezia Bruno; Rosaria M Lista; Orietta Staltari; Antonio Scuteri; Francesca Scicchitano; Emilio Russo
Journal:  J Pharmacol Pharmacother       Date:  2013-12

6.  Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination.

Authors:  Annika M Jödicke; Ivanka Curkovic; Urs Zellweger; Ivan T Tomka; Thomas Neuer; Gerd A Kullak-Ublick; Malgorzata Roos; Marco Egbring
Journal:  Ann Pharmacother       Date:  2018-05-11       Impact factor: 3.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.